|
Name |
Phonmxanthone E
|
Molecular Formula | C34H36O14 | |
IUPAC Name* |
[7-[5-acetyloxy-1,8-dihydroxy-10a-(hydroxymethyl)-6-methyl-9-oxo-6,7-dihydro-5H-xanthen-2-yl]-1,4,8-trihydroxy-3-methyl-9-oxo-3,4,6,7-tetrahydro-2H-xanthen-4a-yl]methylacetate
|
|
SMILES |
CC(=O)OCC12OC3=CCC(c4ccc5c(c4O)C(=O)C4=C(O)CC(C)C(OC(C)=O)C4(CO)O5)C(O)=C3C(=O)C1=C(O)CC(C)C2O
|
|
InChI |
InChI=1S/C34H36O14/c1-13-9-19(38)26-30(43)24-22(48-34(26,31(13)44)12-45-15(3)36)8-6-18(28(24)41)17-5-7-21-23(27(17)40)29(42)25-20(39)10-14(2)32(46-16(4)37)33(25,11-35)47-21/h5,7-8,13-14,18,31-32,35,38-41,44H,6,9-12H2,1-4H3/t13-,14-,18?,31-,32-,33+,34+/m0/s1
|
|
InChIKey |
WMUHZQFVKQWPQR-FCGGQDMGSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 668.65 | ALogp: | 2.8 |
HBD: | 6 | HBA: | 14 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 226.6 | Aromatic Rings: | 6 |
Heavy Atoms: | 48 | QED Weighted: | 0.247 |
Caco-2 Permeability: | -5.386 | MDCK Permeability: | 0.00003370 |
Pgp-inhibitor: | 0.921 | Pgp-substrate: | 0.996 |
Human Intestinal Absorption (HIA): | 0.905 | 20% Bioavailability (F20%): | 0.91 |
30% Bioavailability (F30%): | 0.946 |
Blood-Brain-Barrier Penetration (BBB): | 0.003 | Plasma Protein Binding (PPB): | 82.83% |
Volume Distribution (VD): | 0.297 | Fu: | 14.90% |
CYP1A2-inhibitor: | 0.006 | CYP1A2-substrate: | 0.073 |
CYP2C19-inhibitor: | 0.014 | CYP2C19-substrate: | 0.124 |
CYP2C9-inhibitor: | 0.013 | CYP2C9-substrate: | 0.091 |
CYP2D6-inhibitor: | 0.017 | CYP2D6-substrate: | 0.079 |
CYP3A4-inhibitor: | 0.792 | CYP3A4-substrate: | 0.304 |
Clearance (CL): | 1.259 | Half-life (T1/2): | 0.071 |
hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.922 |
Drug-inuced Liver Injury (DILI): | 0.953 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.999 | Maximum Recommended Daily Dose: | 0.749 |
Skin Sensitization: | 0.028 | Carcinogencity: | 0.022 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.003 |
Respiratory Toxicity: | 0.129 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005070 | 0.626 | D0T5XN | 0.291 | ||||
ENC005074 | 0.576 | D0C9XJ | 0.283 | ||||
ENC004764 | 0.559 | D07VLY | 0.283 | ||||
ENC002870 | 0.523 | D01XWG | 0.280 | ||||
ENC001973 | 0.523 | D01XDL | 0.267 | ||||
ENC005073 | 0.518 | D07IPB | 0.264 | ||||
ENC001991 | 0.512 | D0FX2Q | 0.258 | ||||
ENC003646 | 0.509 | D0G3DL | 0.251 | ||||
ENC005075 | 0.508 | D0T8EH | 0.250 | ||||
ENC002978 | 0.481 | D05CHI | 0.245 |